Scholar Rock Holding (SRRK) Receivables - Other (2022 - 2026)
Scholar Rock Holding's (SRRK) quarterly Receivables - Other came in at $2.8 million in Q1 2026, up 46.35% year-on-year from $1.9 million in Q1 2025, and up 1.64% quarter-over-quarter from $2.8 million in Q4 2025.
Scholar Rock Holding (SRRK) Receivables - Other (2022 - 2026) Analysis & Trends
Scholar Rock Holding's Receivables - Other history runs 5 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- On a quarterly basis, Receivables - Other rose 46.35% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a 46.35% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 30.13% from the prior year.
- Receivables - Other rose to $2.8 million in Q1 2026 per SRRK's latest filing, from $2.8 million in the prior quarter.
- Across five years, Receivables - Other topped out at $3.5 million in Q3 2025 and bottomed at $1.1 million in Q4 2023.
- The 5-year median for Receivables - Other is $2.0 million (2025), against an average of $2.1 million.
- Across the five-year window, Receivables - Other tumbled 60.66% in 2023 and surged 216.88% in 2025, its largest moves.
- Year by year, Receivables - Other stood at $2.7 million in 2022, then tumbled by 60.66% to $1.1 million in 2023, then surged by 99.91% to $2.2 million in 2024, then soared by 30.13% to $2.8 million in 2025, then grew by 1.64% to $2.8 million in 2026.
- Per Business Quant, the three latest SRRK Receivables - Other figures stand at $2.8 million (Q1 2026), $2.8 million (Q4 2025), and $3.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.85 Mn |
| Mar 31, 2026 | 2.85 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 3.55 Mn |
| Sep 30, 2025 | 3.55 Mn |
| Jun 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 1.97 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Dec 31, 2023 | 1.08 Mn |